Clinical Trial

Acute Impact of Whey Protein-enriched Milk Fat Globule Membrane Supplementation on Postprandial Markers of Heart and Brain Health

Recruiting
View on ClinicalTrials.gov →
Summary
In a single-blind, randomised, placebo-controlled crossover manner, this study aims to assess the impact of a high-fat mixed meal containing a whey protein (WP)-enriched milk fat globule membrane (MFGM) powdered ingredient on markers of heart and brain health in the fed state among middle-to-older-aged, postmenopausal women living with overweight and at moderate risk for cardiovascular disease. Participants will attend two \~8 hour study visits, where they will consume a high-fat meal containing a WP-enriched MFGM powdered ingredient or a placebo WP-based powdered ingredient. Each visit will involve anthropometric measurements and periodic assessments of heart health, including blood pressure and blood vessel stiffness measurements, blood sample collections, as well as computer-based tests measuring mood and cognition (brain function) over a 6-hour postprandial period.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-07 -> 2026-10 2026-05-21
minor Completion pushed: 2026-07 -> 2026-10 2026-05-21
Trial Details
NCT Number NCT06953232
Lead Sponsor Loughborough University
Conditions Cardiovascular Diseases, Cognition, Overweight or Obesity, Postmenopausal Women, Cardiometabolic Risk Factors
Enrollment 16 participants
Start Date 2025-09-30
Primary Completion 2026-10 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2026-05-20